secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGIS CORP (RGS)
CIK:        0000716643
Form:       8-K
Filed at:   2021-12-23T23:59:59+00:00
Accession:  0000716643-21-000096
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regis CEO Felipe Athayde resigns; Matt Doctor named Interim CEO
---------------------------------------------------------------

- Felipe Athayde resigns as President and CEO, effective March 19, 2022; remains on Board until then.
- Matthew Doctor appointed Interim CEO effective Dec 23, 2021; base salary raised to $550,000, target 100% incentive, plus $100,000 acceptance bonus.
- Jim Lain appointed COO effective Dec 23, 2021; base salary raised to $425,000, target annual incentive remains at 70%.
- Board commences search for permanent CEO, considering internal and external candidates.
- Michael Ferranti promoted to Executive Vice President and Chief People Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/716643/000071664321000096/0000716643-21-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/716643/000071664321000096/rgs-20211219.htm
  HTML page:      https://secwatch.observer/filing/0000716643-21-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer